Shahrul Mt‐Isa

3.3k total citations
52 papers, 1.3k citations indexed

About

Shahrul Mt‐Isa is a scholar working on Economics and Econometrics, Statistics and Probability and Epidemiology. According to data from OpenAlex, Shahrul Mt‐Isa has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Economics and Econometrics, 15 papers in Statistics and Probability and 8 papers in Epidemiology. Recurrent topics in Shahrul Mt‐Isa's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Statistical Methods in Clinical Trials (12 papers) and Pharmaceutical studies and practices (6 papers). Shahrul Mt‐Isa is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Statistical Methods in Clinical Trials (12 papers) and Pharmaceutical studies and practices (6 papers). Shahrul Mt‐Isa collaborates with scholars based in United Kingdom, United States and Switzerland. Shahrul Mt‐Isa's co-authors include Deborah Ashby, Alicja R. Rudnicka, Christopher G. Owen, Derek G. Cook, Martin Underwood, R E Ferner, Sarah McDowell, Simon Gates, Sarah E Lamb and Mark A. Williams and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shahrul Mt‐Isa

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shahrul Mt‐Isa United Kingdom	19	347	251	232	227	127	52	1.3k
Adam B. Polis United States	20	97 0.3×	267 1.1×	510 2.2×	60 0.3×	325 2.6×	48	1.8k
Elisa Martín‐Merino Spain	19	57 0.2×	54 0.2×	125 0.5×	61 0.3×	69 0.5×	72	1.2k
Josep Franch‐Nadal Spain	30	165 0.5×	138 0.5×	110 0.5×	176 0.8×	343 2.7×	228	3.3k
Mogens Lytken Larsen Denmark	23	43 0.1×	150 0.6×	58 0.3×	139 0.6×	168 1.3×	86	2.0k
Dong Wook Kim South Korea	23	181 0.5×	97 0.4×	26 0.1×	242 1.1×	86 0.7×	92	1.5k
Edward F. Tierney United States	14	68 0.2×	104 0.4×	34 0.1×	83 0.4×	149 1.2×	23	1.4k
A. D. Morris United Kingdom	13	106 0.3×	33 0.1×	40 0.2×	102 0.4×	53 0.4×	19	990
Julien Bezin France	18	21 0.1×	175 0.7×	107 0.5×	23 0.1×	112 0.9×	67	1.2k
Maria I. Aguilar United States	20	45 0.1×	348 1.4×	23 0.1×	314 1.4×	173 1.4×	36	4.7k
Robyn J. Tapp Australia	36	1.1k 3.2×	71 0.3×	80 0.3×	1.3k 5.9×	381 3.0×	80	4.4k

Countries citing papers authored by Shahrul Mt‐Isa

Since Specialization

Citations

This map shows the geographic impact of Shahrul Mt‐Isa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahrul Mt‐Isa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahrul Mt‐Isa more than expected).

Fields of papers citing papers by Shahrul Mt‐Isa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahrul Mt‐Isa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahrul Mt‐Isa. The network helps show where Shahrul Mt‐Isa may publish in the future.

Co-authorship network of co-authors of Shahrul Mt‐Isa

This figure shows the co-authorship network connecting the top 25 collaborators of Shahrul Mt‐Isa. A scholar is included among the top collaborators of Shahrul Mt‐Isa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahrul Mt‐Isa. Shahrul Mt‐Isa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jen, Min‐Hua, Shahrul Mt‐Isa, Haitao Chu, et al.. (2025). The Current Landscape of HTA Framework and Key Challenges. Statistics in Biopharmaceutical Research. 18(1). 64–78.

Mt‐Isa, Shahrul, et al.. (2024). Is inverse probability of censoring weighting a safer choice than per-protocol analysis in clinical trials?. Statistical Methods in Medical Research. 34(2). 286–306. 1 indexed citations

Hair, Gleicy M., Thomas Jemielita, Shahrul Mt‐Isa, Patrick Schnell, & Richard Baumgartner. (2024). Investigating Stability in Subgroup Identification for Stratified Medicine. Pharmaceutical Statistics. 23(6). 945–958.

Levy, Natalie S., Thomas Jemielita, Shahrul Mt‐Isa, et al.. (2024). Use of transportability methods for real-world evidence generation: a review of current applications. Journal of Comparative Effectiveness Research. 13(11). e240064–e240064. 4 indexed citations

Wang, Lin, Arielle G. Bensimon, Murali Sundaram, et al.. (2023). Burden of surgeries and surgical complications in patients with Von Hippel Lindau (VHL) disease before and after treatment with belzutifan.. Journal of Clinical Oncology. 41(6_suppl). 733–733. 2 indexed citations

Mt‐Isa, Shahrul, Mariana Buongermino Pereira, G. C. Chan, et al.. (2020). 1136P Feasibility of linking the UK 100,000 genomes project and real-world evidence databases for a melanoma patient population. Annals of Oncology. 31. S760–S761. 1 indexed citations

Li, Kan, Shuai Yuan, William Yang Wang, et al.. (2018). Periodic benefit-risk assessment using Bayesian stochastic multi-criteria acceptability analysis. Contemporary Clinical Trials. 67. 100–108. 5 indexed citations

Mt‐Isa, Shahrul, Edmond S. Chan, Gerald Downey, et al.. (2016). Recommendations for benefit–risk assessment methodologies and visual representations. Pharmacoepidemiology and Drug Safety. 25(3). 251–262. 56 indexed citations

Dreyer, Nancy A, et al.. (2015). Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership. JMIR Medical Informatics. 3(2). e18–e18. 11 indexed citations

10.

Hallgreen, Christine E., Shahrul Mt‐Isa, A Lieftucht, et al.. (2015). Literature review of visual representation of the results of benefit–risk assessments of medicinal products. Pharmacoepidemiology and Drug Safety. 25(3). 238–250. 18 indexed citations

11.

Chambers, Edward S., Arianna Psichas, Douglas J. Morrison, et al.. (2015). Effects of elevating colonic propionate on liver fat content in overweight adults with non-alcoholic fatty liver disease: a pilot study. Proceedings of The Nutrition Society. 74(OCE1). 4 indexed citations

12.

Mt‐Isa, Shahrul, Mario Ouwens, Véronique Robert, et al.. (2015). Structured Benefit–risk assessment: a review of key publications and initiatives on frameworks and methodologies. Pharmaceutical Statistics. 15(4). 324–332. 30 indexed citations

13.

Williams, Mark A., Esther Williamson, Simon Gates, et al.. (2015). A randomised controlled trial of physiotherapy treatments for patients with acute whiplash associated disorders. Physiotherapy. 101. e816–e816. 2 indexed citations

14.

Mt‐Isa, Shahrul, Edmond S. Chan, Gerald Downey, et al.. (2014). IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 13 indexed citations

15.

Lamb, Sarah E, Mark A. Williams, Esther Williamson, et al.. (2012). Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries. Health Technology Assessment. 16(49). iii–iv, 1. 28 indexed citations

16.

Tan, Tricia, Benjamin C. T. Field, James Minnion, et al.. (2011). Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420. British Journal of Clinical Pharmacology. 73(2). 232–239. 28 indexed citations

17.

Peters, Ruth, Nigel Beckett, Robert Beardmore, et al.. (2010). Modelling Cognitive Decline in the Hypertension in the Very Elderly Trial [HYVET] and Proposed Risk Tables for Population Use. PLoS ONE. 5(7). e11775–e11775. 11 indexed citations

18.

Underwood, Martin, Deborah Ashby, Dawn Carnes, et al.. (2008). Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. Health Technology Assessment. 12(22). iii–iv, ix. 43 indexed citations

19.

Lamb, Sarah E, Simon Gates, Martin Underwood, et al.. (2007). Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disorders. BMC Musculoskeletal Disorders. 8(1). 7–7. 27 indexed citations

20.

Underwood, Martin, Deborah Ashby, Pamela L Cross, et al.. (2007). Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ. 336(7636). 138–142. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact